These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29029628

  • 1. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M, Bednar M, Frei K, Gassmann M, Ogunshola OO.
    J Neuroinflammation; 2017 Oct 13; 14(1):202. PubMed ID: 29029628
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK.
    Clin Exp Immunol; 2010 Nov 13; 162(2):210-23. PubMed ID: 21069936
    [Abstract] [Full Text] [Related]

  • 3. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R, de Carvalho AC, Alves da Costa T, Ishikawa LL, Fraga-Silva TF, Sartori A, de Oliveira AL, Verinaud L.
    CNS Neurosci Ther; 2016 Aug 13; 22(8):707-14. PubMed ID: 27165523
    [Abstract] [Full Text] [Related]

  • 4. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV.
    J Neuroinflammation; 2016 Jun 29; 13(1):169. PubMed ID: 27357191
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV.
    J Neuroinflammation; 2019 Mar 20; 16(1):64. PubMed ID: 30894198
    [Abstract] [Full Text] [Related]

  • 7. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.
    Yuan R, Maeda Y, Li W, Lu W, Cook S, Dowling P.
    PLoS One; 2008 Apr 02; 3(4):e1924. PubMed ID: 18382691
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, Hidalgo J, García A.
    Exp Neurol; 2014 Jan 02; 251():58-71. PubMed ID: 24211383
    [Abstract] [Full Text] [Related]

  • 10. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
    Valentin-Torres A, Savarin C, Hinton DR, Phares TW, Bergmann CC, Stohlman SA.
    J Neuroinflammation; 2016 Feb 22; 13():46. PubMed ID: 26906225
    [Abstract] [Full Text] [Related]

  • 11. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG.
    J Neuroinflammation; 2016 Feb 01; 13():24. PubMed ID: 26831924
    [Abstract] [Full Text] [Related]

  • 12. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas SS, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L.
    Exp Neurol; 2015 May 01; 267():254-67. PubMed ID: 25447934
    [Abstract] [Full Text] [Related]

  • 13. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
    Mills Ko E, Ma JH, Guo F, Miers L, Lee E, Bannerman P, Burns T, Ko D, Sohn J, Soulika AM, Pleasure D.
    J Neuroinflammation; 2014 Jun 12; 11():105. PubMed ID: 24924222
    [Abstract] [Full Text] [Related]

  • 14. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E, Chanamara S, Pleasure D, Soulika AM.
    J Neuroinflammation; 2012 Jan 16; 9():7. PubMed ID: 22248039
    [Abstract] [Full Text] [Related]

  • 15. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P, Touloumi O, Lagoudaki R, Nousiopoulou E, Kesidou E, Siafis S, Tselios T, Lourbopoulos A, Karacostas D, Grigoriadis N, Simeonidou C.
    J Neuroinflammation; 2016 Oct 11; 13(1):265. PubMed ID: 27724971
    [Abstract] [Full Text] [Related]

  • 16. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
    Zilkha-Falb R, Kaushansky N, Kawakami N, Ben-Nun A.
    J Neuroinflammation; 2016 Jan 08; 13():7. PubMed ID: 26747276
    [Abstract] [Full Text] [Related]

  • 17. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
    Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika AM, Pleasure D.
    J Neurosci; 2014 Jun 11; 34(24):8175-85. PubMed ID: 24920622
    [Abstract] [Full Text] [Related]

  • 18. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y, Chung SK, Siu CW, Kwan SC, Ho PW, Yeung PK, Chan KH.
    J Neuroimmunol; 2014 Nov 15; 276(1-2):64-70. PubMed ID: 25205217
    [Abstract] [Full Text] [Related]

  • 19. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.
    Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL, Bethea JR.
    Glia; 2014 Mar 15; 62(3):452-67. PubMed ID: 24357067
    [Abstract] [Full Text] [Related]

  • 20. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
    Nuro-Gyina PK, Rieser EL, Granitto MC, Pei W, Liu Y, Lee PW, Aqel S, Zhang J, Lovett-Racke AE, Racke MK, Yang Y.
    J Neuroinflammation; 2016 Dec 03; 13(1):302. PubMed ID: 27912762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.